Month: April 2025

A Media Snippet accompanying this announcement is available by clicking on this link. AMSTERDAM, April 29, 2025 (GLOBE NEWSWIRE) — Whether it’s pulling on a lucky jersey or claiming the same barstool before kick-off, football fans around the world have many of their own matchday superstitions. And according to a new global survey commissioned by Heineken®, half of fans say they follow a specific ritual on game day—and nearly as many (46%) believe it genuinely impacts the outcome. Younger fans are leading the charge – 67% of Gen Z and Millennial fans say they’ve got a pre-match ritual, while only 26% of fans over 55 admit to doing the same. For this next generation of hardcore fans, it seems belief is half the battle. Heineken® understands that football is more than a game—it’s a global passion shaped by loyalty and...

AD HOC ANNOUNCEMENT PURSUANT TO ART. 53 LRFIRST QUARTER | 2025Q1 2025 sales increased by 1 % in local currencies1 to CHF 1.013 billion, driven by organic growth in Care Chemicals and Adsorbents & Additives, supported by scope and slightly positive pricing Lucas Meyer Cosmetics by Clariant delivering strong operational performance with CHF 25 million in sales and a continued high level of profitability Q1 2025 EBITDA margin before exceptional items improved 70 basis points to 18.8 % from 18.1 % in Q1 2024, driven by strong profitability in all businesses, with reported EBITDA margin impacted by CHF 38 million restructuring charges Performance program of CHF 175 million completed on schedule with achievement of additional cost savings of CHF 5 million, implementation of additional Investor Day savings program of CHF 80 million...

Vivoryon Therapeutics N.V. Reports Full Year 2024 Financial Results and Provides Business UpdateSuccessful strategic shift towards a focus on inflammatory and fibrotic diseases, in particular on kidney disease Varoglutamstat Phase 2 program shows highly consistent, statistically significant and clinically meaningful improvement of kidney function (eGFR) versus placebo in two independent randomized double-blind placebo-controlled studies Statistical evidence from meta-analysis of VIVIAD and VIVA-MIND enables efficient design of Phase 2b study in diabetic kidney disease (DKD), ideally suited to evaluate varoglutamstat in the intended target population of stage 3b and worse, and to maximize probability of success in kidney disease VIVIAD Phase 2b results of varoglutamstat on kidney function highlighted as late-breaking oral presentation...

GUADALAJARA, Mexico, April 29, 2025 (GLOBE NEWSWIRE) — Grupo Aeroportuario del Pacífico, S.A.B. de C.V. (NYSE: PAC; BMV: GAP) (“the Company” or “GAP”) reports its consolidated results for the first quarter ended March 31, 2025 (1Q25). Figures are unaudited and prepared following International Financial Reporting Standards (“IFRS”) as issued by the International Accounting Standards Board (“IASB”). Summary of Results 1Q25 vs. 1Q24The sum of aeronautical and non-aeronautical services revenues increased by Ps. 1,736.5 million, or 26.1%. Total revenues increased by Ps. 2,560.2 million, or 30.1%.Cost of services increased by Ps. 412.9 million, or 38.5%.Income from operations increased by Ps. 710.2 million, or 17.8%.EBITDA increased by Ps. 979.8 million, or 21.1%, from Ps. 4,649.0 million in 1Q24 to Ps. 5,628.8 million in...

The General Meeting of Shareholders of AB Kauno Energija (identification code 235014830, address Raudondvario str. 84, Kaunas, LT-47179) that has been held on 28 April 2025 decided to allocate EUR 0.02435 dividend per share. AB Kauno Energija (trading code KNR1L, ISIN code LT0000123010) will close the list of shareholders for dividend payment on 13 May 2025 at the end of the working day of the settlement system. Proceeding from the above, the ex-date is 12 May 2025. From that date the new owner of the shares, which were acquired on stock exchange with settlement cycle of T+2, is not entitled to dividends for the year 2024.

SANTIAGO, Chile, April 28, 2025 (GLOBE NEWSWIRE) — BANCO ITAÚ CHILE (SSE: ITAUCL) announced today that its conference call to discuss the financial results of the first quarter 2025 will be held on Thursday, May 8, 2025, at 9:00 A.M. Santiago time (9:00 A.M. ET). The conference call will be hosted by the by André Gailey, CEO; Emiliano Muratore, CFO; and Andrés Perez, Chief Economist. The results for the first quarter ended March 31, 2025 will be released before the market opens in Santiago, on April 30, 2025. Webinar Details: Online registration:  https://mzgroup.zoom.us/webinar/register/WN_jun0W4C_RSCXLRHeMsyD4A#/registration All participants must pre-register using this link to join the webinar. Upon registering, each participant will be provided with details to connect to the call. Q&A session: The Q&A session will...

LAS VEGAS, April 28, 2025 (GLOBE NEWSWIRE) — GBank Financial Holdings Inc. (the “Company”) (OTCQX: GBFH), the parent company of GBank (the “Bank”), announced today that its shares of common stock have been approved for listing on the Nasdaq Capital Market and are expected to commence trading on April 30, 2025, under the ticker symbol “GBFH.” The Company’s shares will continue to trade on the OTCQX until trading on Nasdaq commences. Shareholders are not required to take any action as a result of the uplisting, and the Company’s ticker symbol “GBFH” will remain unchanged. Edward M. Nigro, Executive Chairman, added, “Trading on the NASDAQ Capital Market culminates our efforts to provide shareholders with liquidity and consequential share value—thank you for believing in us and supporting us these many years—we look forward to many...

Vancouver, Canada, April 28, 2025 (GLOBE NEWSWIRE) — Oroco Resource Corp. (TSX-V: OCO, OTC: ORRCF) (“Oroco” or the “Company”).  is pleased to announce that it has filed and obtained a receipt for a final short form base shelf prospectus (the “Prospectus“) with the securities commissions in each of the provinces and territories of Canada, excluding Quebec. The Prospectus allows the Company to qualify the distribution of up to C$75,000,000 of common shares, warrants, subscription receipts, units, debt securities, or any combination thereof during the 25-month period that the Prospectus remains effective. The Prospectus is intended to provide the Company with the flexibility to take advantage of financing opportunities and favourable market conditions.  Should the Company decide to offer securities under the Prospectus, the specific...